$ARWR Study Type : Interventional (Clinical Trial) Estimated Enrollment : 94 participants Allocation: Randomized Intervention Model: Sequential Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Treatment Official Title: A Phase 1 Single and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of ARO-ANG3 in Adult Healthy Volunteers and in Dyslipidemic Patients Actual Study Start Date : January 7, 2019 Estimated Primary Completion Date : May 28, 2021 Estimated Study Completion Date : May 28, 2021 Don't be sleeping on our Cardio drugs... we could have another data readout before the end of Q2 with an end date of May28th! that would make it five with a possibility of six with JNJ-3989 all within 62 trading days!